Yeah tomorrow morning will be interesting to say the least.
I doubt they have any data readouts that will be stellar. If they did, they would've released them a long time ago and got the SP above $1 to avoid delisting and RS. Consider:
- $12 million shares given away for free
- no partnership in sight
- paying for all these expensive trials while running on fumes
- biggest paying partner bailed out a few months ago,
- incompetent and untrustworthy executives and BOD
- Second RS in just under 6 years.
- EMA application withdrawn
- No revenue
- No likelihood of any FDA approval without a very expensive trial in another 3-4 years, hence no likelihood of revenue stream in 3-4 years at least.
- CMO and CSO who have NOTHING to show for 25 years of work except a list of useless patents that are worth less than toilet paper.
This company sure has a lot going for it, doesn't it?
I say short the bejeezus out of this stinking POS and recover some of your losses.
Market Data 
Markets 
AI
